- 专利标题： Spiro-oxindole compounds and their use as therapeutic agents
-
申请号： US12577799申请日： 2009-10-13
-
公开(公告)号： US08101647B2公开(公告)日： 2012-01-24
- 发明人: Mikhail Chafeev , Sultan Chowdhury , Lauren Fraser , Jianmin Fu , Jonathan Langille , Shifeng Liu , Jianyu Sun , Shaoyi Sun , Serguei Sviridov , Mark Wood , Alla Zenova
- 申请人： Mikhail Chafeev , Sultan Chowdhury , Lauren Fraser , Jianmin Fu , Jonathan Langille , Shifeng Liu , Jianyu Sun , Shaoyi Sun , Serguei Sviridov , Mark Wood , Alla Zenova
- 申请人地址： CA Burnaby, B.C.
- 专利权人： Xenon Pharmaceuticals Inc.
- 当前专利权人： Xenon Pharmaceuticals Inc.
- 当前专利权人地址： CA Burnaby, B.C.
- 代理机构： Seed IP Law Group PLLC
- 主分类号： C07D491/10
- IPC分类号： C07D491/10 ; A61K31/404
摘要：
This invention is directed to spiro-oxindole compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.
公开/授权文献
信息查询
